000 | 01164 a2200301 4500 | ||
---|---|---|---|
005 | 20250514012344.0 | ||
264 | 0 | _c20011101 | |
008 | 200111s 0 0 eng d | ||
022 | _a0160-6689 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHenderson, D C | |
245 | 0 | 0 |
_aClozapine: diabetes mellitus, weight gain, and lipid abnormalities. _h[electronic resource] |
260 |
_bThe Journal of clinical psychiatry _c2001 |
||
300 |
_a39-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aClozapine _xadverse effects |
650 | 0 | 4 |
_aDiabetes Mellitus _xchemically induced |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xchemically induced |
650 | 0 | 4 |
_aDiabetic Ketoacidosis _xchemically induced |
650 | 0 | 4 | _aGlucose Tolerance Test |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperlipidemias _xchemically induced |
650 | 0 | 4 |
_aHypertriglyceridemia _xchemically induced |
650 | 0 | 4 |
_aSchizophrenia _xblood |
650 | 0 | 4 |
_aWeight Gain _xdrug effects |
773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 62 Suppl 23 _gp. 39-44 |
|
999 |
_c11523504 _d11523504 |